The U.S. Food and Drug Administration on Wednesday approved a new version of the type 2 diabetes drug tirzepatide for use in chronic weight management, officials said.
Theresa Seiger, Cox Media Group National Content DeskFILE PHOTO: The FDA has approved Eli Lilly's diabetes drug Mounjaro to be used to treat obesity.November 08, 2023 at 10:04 am PST
Regulators previously approved the drug for treatment of diabetes under the name Mounjaro. The version approved for weight loss is called Zepbound. We approved a new injection for chronic weight management in adults with obesity or overweight with at least one weight-related condition , to use in addition to a reduced calorie diet and increased physical…
Norge Siste Nytt, Norge Overskrifter
Similar News:Du kan også lese nyheter som ligner på denne som vi har samlet inn fra andre nyhetskilder.
FDA approves Eli Lilly’s Zepbound, a weight loss drug similar to Ozempic and WegovyBerkeley Lovelace Jr. is a health and medical reporter for NBC News. He covers the Food and Drug Administration, with a special focus on Covid vaccines, prescription drug pricing and health care. He previously covered the biotech and pharmaceutical industry with CNBC.
Les mer »
FDA approves new version of diabetes drug Mounjaro for weight lossFederal regulators say a new version of the popular diabetes treatment Mounjaro can be sold as a weight-loss drug
Les mer »
FDA approves new obesity drug from Eli Lilly named ZepboundThe decision by the Food and Drug Administration is expected to add to the demand for a new class of drugs transforming how patients battle obesity.
Les mer »
FDA approves new version of diabetes drug Mounjaro for weight lossFederal regulators say a new version of the popular diabetes treatment Mounjaro can be sold as a weight-loss drug. The Food and Drug Administration approved Zepbound on Wednesday. The drug has been shown to help dieters lose about a quarter of their body weight, or 60 pounds.
Les mer »
FDA approves new version of diabetes drug Mounjaro for weight lossA new version of the popular diabetes treatment Mounjaro can be sold as a weight-loss drug, U.S. regulators announced Wednesday.
Les mer »
FDA approves new version of diabetes drug Mounjaro for weight lossFederal regulators say a new version of the popular diabetes treatment Mounjaro can be sold as a weight-loss drug.
Les mer »